CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-13 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion | +13,849 | $16.00 | $222K | 13,849 |
| 2020-09-09 | Galbraith Kenneth Director | Sale | −13,849 | $27.11 | $375K | 0 |
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion | +6,924 | $20.15 | $140K | 6,924 |
| 2020-09-09 | Galbraith Kenneth Director | Sale | −6,924 | $27.11 | $188K | 0 |
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion · Stock Option (right to buy) | −13,849 | 0 | ||
| 2020-09-09 | Galbraith Kenneth Director | Exercise or conversion · Stock Option (right to buy) | −6,924 | 0 | ||
| 2020-05-14 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2019-05-16 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 1 of 1 · 10 trades